Doryx Mpc (Doxycycline Hyclate) Patent Expiration, LOE Window & CMS Spending

Doryx Mpc (Doxycycline Hyclate) by Mayne International Pty: FDA Orange Book LOE 2034-12-23, 4 AB generics, $1.3M 2024 CMS Part D & Medicaid spend, and $1,200 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMayne International Pty
FDA Application & PathwayN050795 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2034-12-23
Orange Book Patents (*PED Extensions)4 patents (0 *PED)
Active AB-Rated Generic Competitors4
2024 CMS Total Public Spend$1.3M
2024 Medicare Part D Spend$244K
2024 Medicaid Spend$1.1M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,200 intro WAC)